Aimmune Therapeutics Inc (AIMT) Return on Assets ROA from the second quarter of 2020 to second quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Jun 30 2020 to Jun 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aimmune Therapeutics Inc   (NASDAQ: AIMT)


Aimmune Therapeutics Inc 's ROA from the second quarter of 2020 to the second quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Aimmune Therapeutics Inc 's ROA in the second quarter of 2020?
Aimmune Therapeutics Inc recorded a cumulative net loss of $-287 million during 12 months ending in the second quarter of 2020, resulting in a negative return on assets (ROA) of -96.38%.

However, within the Healthcare sector 733 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2020 quarter, so far to 4501, from total ROA ranking in the first quarter of 2020 at 4567.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Total Assets Change 23.66 % 22.55 % -43.35 % -17.91 % -12.28 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -287 -281 -248 -239 -226
Return On Assets (TTM) -96.38 % -99.93 % -94.82 % -79.83 % -72.45 %
AIMT's Total Ranking # 4501 # 4567 # 5072 # 4501 # 4491
Total Assets (TTM) in million 354 409 192 236 287
Seq. Total Assets Change -13.28 % 112.42 % -18.49 % -17.64 % -14.06 %
Seq. Net Income Change - - - - -

AIMT's 5 Years Annual ROA >> Back to AIMT Management Effectiveness >> Compare AIMT ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 358
Sector # 734
Overall # 4344

Return On Assets Statistics
High Average Low
-3.63 %
-60.28 %
-95.82 %
(Jun 30 2015)   (Mar 31 2020)





Financial Statements
Aimmune Therapeutics Inc 's Assets $ 354 million AIMT's Balance sheet
Aimmune Therapeutics Inc 's Income $ -69 million Quarterly AIMT's Income Statement
AIMT's Income by Division See AIMT's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015
Y / Y Total Assets Change -43.35 % 64.09 % -30.74 % 40.7 % -
Total Assets in million 192 340 207 299 212
Y / Y Net Income Change - - - - -
Net Income in million -248 -211 -131 -81 -36
Annual Return On Assets -129.2 % -62.07 % -63.46 % -27.05 % -16.87 %

AIMT's 5 Years Annual ROA >> Back to AIMT Management Effectiveness >> Compare AIMT ROA to its Competitors



More Return On Assets Ratios
AIMT's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AIMT's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for AIMT's Competitors
Subscribers only: Roa for Aimmune Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for AIMT's Customers

You may also want to know
AIMT's Roi AIMT's Inventory Turnover Ratio AIMT's Growth Rates AIMT's Dividend Comparisons
AIMT's Profitability Ratios AIMT's Asset Turnover Ratio AIMT's Dividend Growth
AIMT's Roe AIMT's Valuation Ratios AIMT's Financial Strength Ratios AIMT's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2020, within Healthcare Sector ROA

Date modified: 2026-09-12T06:20:58+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.